Cargando…

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration

PURPOSE: To evaluate the pharmacokinetic properties of besifloxacin, gatifloxacin, and moxifloxacin in the conjunctival tissue of healthy volunteers after topical application. METHODS: One-hundred eight (108) subjects were randomly assigned to receive one drop of besifloxacin (0.6% suspension), gati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torkildsen, Gail, Proksch, Joel W, Shapiro, Aron, Lynch, Stephanie K, Comstock, Timothy L
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861941/ https://www.ncbi.nlm.nih.gov/pubmed/20463802

Ejemplares similares

Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin
por: Sugioka, Koji, et al.
Publicado: (2009)

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
por: Bucci, Frank A, et al.
Publicado: (2015)

Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery
por: dos Santos, Giselly Almeida, et al.
Publicado: (2020)

Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates
por: Sanfilippo, Christine M., et al.
Publicado: (2017)

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis
por: Comstock, Timothy L, et al.
Publicado: (2010)

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
por: Ruan, Qiaoling, et al.
Publicado: (2016)

In vivo 3D measurement of moxifloxacin and gatifloxacin distributions in the mouse cornea using multiphoton microscopy
por: Lee, Seunghun, et al.
Publicado: (2016)

Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial Infections
por: Mah, Francis S., et al.
Publicado: (2016)

Comparative Study of Ocular Pharmacokinetics of Topical 0.3% Gatifloxacin Eye Gel and Solution in Rabbits
por: Liu, Manli, et al.
Publicado: (2022)

The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora
por: Celebi, Ali Riza Cenk, et al.
Publicado: (2021)

Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
por: Pienaar, Elsje, et al.
Publicado: (2017)

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
por: Silverstein, Bruce E, et al.
Publicado: (2012)

Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations
por: Khurana, Gaurav, et al.
Publicado: (2012)

Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections
por: Youssef, Ahmed Adel Ali, et al.
Publicado: (2022)

An Evaluation of Staphylococci from Ocular Surface Infections Treated Empirically with Topical Besifloxacin: Antibiotic Resistance, Molecular Characteristics, and Clinical Outcomes
por: Schechter, Barry A., et al.
Publicado: (2019)

Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3% Gatifloxacin and 0.5% Levofloxacin Ophthalmic Solutions
por: Ding, Wenting, et al.
Publicado: (2015)

The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis
por: He, Yiyue, et al.
Publicado: (2022)

In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride
por: Blondeau, Joseph, et al.
Publicado: (2021)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
por: Morris, Timothy W, et al.
Publicado: (2011)

Comparison of Aqueous Humour Concentration after Single High Dose Versus Multiple Administration of Topical Moxifloxacin in Rabbits
por: Chopra, Monika, et al.
Publicado: (2014)

Bilayered Films Based on Novel Polymer Derivative for Improved Ocular Therapy of Gatifloxacin
por: Aher, Naval Dinesh, et al.
Publicado: (2014)

Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
por: Chaugule, Sonal S, et al.
Publicado: (2018)

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
por: Jawahar, Mohideen S., et al.
Publicado: (2013)

Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation
por: de Jesus, José Izo Santana da Silva, et al.
Publicado: (2022)

Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae
por: Haas, Wolfgang, et al.
Publicado: (2010)

Nano-Formulating Besifloxacin and Employing Quercetin as a Synergizer to Enhance the Potency of Besifloxacin against Pathogenic Bacterial Strains: A Nano-Synergistic Approach
por: Al Hagbani, Turki, et al.
Publicado: (2023)

Corneal deposits following topical moxifloxacin use
por: Alshamrani, Abdulaziz A., et al.
Publicado: (2019)

Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK
por: Campos, Mauro, et al.
Publicado: (2011)

Comparative evaluation of aqueous and plasma concentration of topical moxifloxacin alone and with flurbiprofen in patients of cataract surgery
por: Halder, Sujash, et al.
Publicado: (2013)

Efficacy of Gatifloxacin in Acute Bacterial Corneal ulcer
por: Afzal Junejo, Sameen, et al.
Publicado: (2013)

Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones
por: Haas, Wolfgang, et al.
Publicado: (2013)

Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin Therapy
por: Hinkle, David M, et al.
Publicado: (2017)

An Update on Ocular Surface Epithelial Stem Cells: Cornea and Conjunctiva
por: Ramos, Tiago, et al.
Publicado: (2015)

Synthesis and Characterization of Potential Dimers of Gatifloxacin – an Antibacterial Drug
por: Garaga, Srinivas, et al.
Publicado: (2013)

Ultrasound-assisted gatifloxacin delivery in mouse cornea, in vivo
por: Jegal, Uk, et al.
Publicado: (2019)

Safety of Besifloxacin Ophthalmic Suspension 0.6% in Cataract and LASIK Surgery Patients
por: Majmudar, Parag A., et al.
Publicado: (2014)

Besifloxacin Ophthalmic Suspension: Emerging Evidence of its Therapeutic Value in Bacterial Conjunctivitis
por: Khimdas, S., et al.
Publicado: (2011)

Topical moxifloxacin-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Dhavaleshwar, A, et al.
Publicado: (2019)

Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system
por: Kesavan, K., et al.
Publicado: (2010)

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
por: Cervantes, Lorenzo J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kr8naicv3rk4134mf6g72mfa53